These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

940 related items for PubMed ID: 19768385

  • 1. Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile.
    Yang H, Zhang Y, Wu M, Li J, Zhou W, Li G, Li X, Xiao B, Christadoss P.
    Inflamm Res; 2010 Mar; 59(3):197-205. PubMed ID: 19768385
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Atorvastatin-modified dendritic cells in vitro ameliorate experimental autoimmune myasthenia gravis by up-regulated Treg cells and shifted Th1/Th17 to Th2 cytokines.
    Li XL, Liu Y, Cao LL, Li H, Yue LT, Wang S, Zhang M, Li XH, Dou YC, Duan RS.
    Mol Cell Neurosci; 2013 Sep; 56():85-95. PubMed ID: 23541702
    [Abstract] [Full Text] [Related]

  • 4. T-bet deficiency decreases susceptibility to experimental myasthenia gravis.
    Liu R, Hao J, Dayao CS, Shi FD, Campagnolo DI.
    Exp Neurol; 2009 Dec; 220(2):366-73. PubMed ID: 19818352
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. RNA interference targeting Bcl-6 ameliorates experimental autoimmune myasthenia gravis in mice.
    Xin N, Fu L, Shao Z, Guo M, Zhang X, Zhang Y, Dou C, Zheng S, Shen X, Yao Y, Wang J, Wang J, Cui G, Liu Y, Geng D, Xiao C, Zhang Z, Dong R.
    Mol Cell Neurosci; 2014 Jan; 58():85-94. PubMed ID: 24361642
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4.
    Im SH, Barchan D, Maiti PK, Fuchs S, Souroujon MC.
    J Immunol; 2001 Jun 01; 166(11):6893-8. PubMed ID: 11359850
    [Abstract] [Full Text] [Related]

  • 10. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis.
    Xiao BG, Duan RS, Zhu WH, Lu CZ.
    Cell Immunol; 2006 Jun 01; 241(2):95-101. PubMed ID: 17005165
    [Abstract] [Full Text] [Related]

  • 11. Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells.
    Duan RS, Adikari SB, Huang YM, Link H, Xiao BG.
    Neurobiol Dis; 2004 Jul 01; 16(2):461-7. PubMed ID: 15193302
    [Abstract] [Full Text] [Related]

  • 12. Shenghua Decoction reduces uterine bleeding and regulates T-cell paradigm in human deciduas of RU486 medical abortion.
    Li X, Zhang M, Wang B, Li Y, Wang L, Zhao X, Zhou X, Guo Y, Jiang G, Yao C.
    J Ethnopharmacol; 2013 Dec 12; 150(3):907-17. PubMed ID: 24140602
    [Abstract] [Full Text] [Related]

  • 13. ATRA alters humoral responses associated with amelioration of EAMG symptoms by balancing Tfh/Tfr helper cell profiles.
    Xie X, Mu L, Yao X, Li N, Sun B, Li Y, Zhan X, Wang X, Kang X, Wang J, Liu Y, Zhang Y, Wang G, Wang D, Liu X, Kong Q, Li H.
    Clin Immunol; 2013 Aug 12; 148(2):162-76. PubMed ID: 23773919
    [Abstract] [Full Text] [Related]

  • 14. Imbalances in T Cell-Related Transcription Factors Among Patients with Hashimoto's Thyroiditis.
    Safdari V, Alijani E, Nemati M, Jafarzadeh A.
    Sultan Qaboos Univ Med J; 2017 May 12; 17(2):e174-e180. PubMed ID: 28690889
    [Abstract] [Full Text] [Related]

  • 15. Exosomes derived from atorvastatin-modified bone marrow dendritic cells ameliorate experimental autoimmune myasthenia gravis by up-regulated levels of IDO/Treg and partly dependent on FasL/Fas pathway.
    Li XL, Li H, Zhang M, Xu H, Yue LT, Zhang XX, Wang S, Wang CC, Li YB, Dou YC, Duan RS.
    J Neuroinflammation; 2016 Jan 12; 13():8. PubMed ID: 26757900
    [Abstract] [Full Text] [Related]

  • 16. Suppression of experimental autoimmune myasthenia gravis by granulocyte-macrophage colony-stimulating factor is associated with an expansion of FoxP3+ regulatory T cells.
    Sheng JR, Li L, Ganesh BB, Vasu C, Prabhakar BS, Meriggioli MN.
    J Immunol; 2006 Oct 15; 177(8):5296-306. PubMed ID: 17015715
    [Abstract] [Full Text] [Related]

  • 17. Suppression of experimental autoimmune myasthenia gravis by autologous T regulatory cells.
    Aricha R, Reuveni D, Fuchs S, Souroujon MC.
    J Autoimmun; 2016 Feb 15; 67():57-64. PubMed ID: 26489998
    [Abstract] [Full Text] [Related]

  • 18. Lentiviral-mediated shRNA against RelB induces the generation of tolerogenic dendritic cells.
    Qiu T, Zhu HC, Liu XH, Dong WC, Weng XD, Hu CH, Kuang YL, Gao RH, Dan C, Tao T.
    Int Immunopharmacol; 2012 Mar 15; 12(3):501-9. PubMed ID: 22266276
    [Abstract] [Full Text] [Related]

  • 19. IL-17-producing CD4(+) T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis.
    Schaffert H, Pelz A, Saxena A, Losen M, Meisel A, Thiel A, Kohler S.
    Eur J Immunol; 2015 May 15; 45(5):1339-47. PubMed ID: 25676041
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.